Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology

B. Moura*, A. Aimo, A. Al-Mohammad, A. Flammer, V. Barberis, A. Bayes-Genis, H.P. Brunner-La Rocca, R. Fontes-Carvalho, J. Grapsa, M. Hulsmann, N. Ibrahim, C. Knackstedt, J.L. Januzzi, T. Lapinskas, A. Sarrias, S. Matskeplishvili, W.C. Meijers, D. Messroghli, C. Mueller, N. PavoA.J. Teske, R. Kimmenade, P. Seferovic, A.J.S. Coats, M. Emdin, A.M. Richards

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

14 Citations (Web of Science)

Abstract

Circulating biomarkers and imaging techniques provide independent and complementary information to guide management of heart failure (HF). This consensus document by the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) presents current evidence-based indications relevant to integration of imaging techniques and biomarkers in HF. The document first focuses on application of circulating biomarkers together with imaging findings, in the broad domains of screening, diagnosis, risk stratification, guidance of treatment and monitoring, and then discusses specific challenging settings. In each section we crystallize clinically relevant recommendations and identify directions for future research. The target readership of this document includes cardiologists, internal medicine specialists and other clinicians dealing with HF patients.
Original languageEnglish
Pages (from-to)1577-1596
Number of pages20
JournalEuropean journal of heart failure
Volume23
Issue number10
Early online date14 Sept 2021
DOIs
Publication statusPublished - Oct 2021

Keywords

  • Biomarkers
  • Imaging
  • Diagnosis
  • Management
  • Heart failure
  • Consensus document
  • PRESERVED EJECTION FRACTION
  • BRAIN NATRIURETIC PEPTIDE
  • SPECKLE-TRACKING ECHOCARDIOGRAPHY
  • CARDIOVASCULAR MAGNETIC-RESONANCE
  • DIFFUSE MYOCARDIAL FIBROSIS
  • LATE GADOLINIUM ENHANCEMENT
  • WORSENING RENAL-FUNCTION
  • INDIVIDUAL PATIENT DATA
  • 2013 ACCF/AHA GUIDELINE
  • SUDDEN CARDIAC DEATH

Cite this